Study of Gemcitabine and Carboplatin in the Treatment of Metastatic or Recurrent Cholangiocarcinoma/Gallbladder Cancer
Status:
Completed
Trial end date:
2009-04-01
Target enrollment:
Participant gender:
Summary
To determine the activity of gemcitabine combined with carboplatin in the treatment of
patients with metastatic or recurrent cholangiocarcinoma or gallbladder cancer.